======= ACSM1 =======
== Gene Information ==
* **Official Symbol**: ACSM1
* **Official Name**: acyl-CoA synthetase medium chain family member 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=116285|116285]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q08AH1|Q08AH1]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ACSM1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ACSM1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/614357|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Has medium-chain fatty acid:CoA ligase activity with broad substrate specificity (in vitro). Acts on acids from C(4) to C(11) and on the corresponding 3-hydroxy- and 2,3- or 3,4- unsaturated acids (in vitro). Functions as GTP-dependent lipoate- activating enzyme that generates the substrate for lipoyltransferase (By similarity). {ECO:0000250}.
|AMP-binding|
|benzoate metabolic process|
|butyrate metabolic process|
|fatty acid ligase activity|
|fatty-acyl-CoA synthase activity|
|butyrate-CoA ligase activity|
|acyl-CoA ligase activity|
|short-chain fatty acid metabolic process|
|benzene-containing compound metabolic process|
|fatty acid oxidation|
|lipid oxidation|
|cholesterol homeostasis|
|sterol homeostasis|
|thioester metabolic process|
|acyl-CoA metabolic process|
|antibiotic metabolic process|
|fatty acid biosynthetic process|
|xenobiotic metabolic process|
|ribonucleoside bisphosphate metabolic process|
|nucleoside bisphosphate metabolic process|
|purine nucleoside bisphosphate metabolic process|
|lipid homeostasis|
|blood microparticle|
|monocarboxylic acid biosynthetic process|
|cellular response to xenobiotic stimulus|
|lipid modification|
|energy derivation by oxidation of organic compounds|
|coenzyme metabolic process|
|response to xenobiotic stimulus|
|carboxylic acid biosynthetic process|
|organic acid biosynthetic process|
|purine ribonucleotide metabolic process|
|fatty acid metabolic process|
|ribonucleotide metabolic process|
|purine nucleotide metabolic process|
|ribose phosphate metabolic process|
|sulfur compound metabolic process|
|purine-containing compound metabolic process|
|mitochondrial matrix|
|GTP binding|
|generation of precursor metabolites and energy|
|cofactor metabolic process|
|nucleotide metabolic process|
|nucleoside phosphate metabolic process|
|drug metabolic process|
|monocarboxylic acid metabolic process|
|nucleobase-containing small molecule metabolic process|
|lipid biosynthetic process|
|small molecule biosynthetic process|
|cellular amide metabolic process|
|organophosphate metabolic process|
|carboxylic acid metabolic process|
|cellular lipid metabolic process|
|oxidation-reduction process|
|oxoacid metabolic process|
|organic acid metabolic process|
|carbohydrate derivative metabolic process|
|chemical homeostasis|
|lipid metabolic process|
|ATP binding|
|homeostatic process|
|small molecule metabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp116|AICAR 240μM R03 exp116]]|-2.14|
|[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|1.7|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4919
* **Expression level (log2 read counts)**: -4.27
{{:chemogenomics:nalm6 dist.png?nolink |}}